Skip to content

Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid

Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid,Phase 4.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01693055
Enrollment
7
Registered
2012-09-26
Start date
2012-09-30
Completion date
2013-02-28
Last updated
2014-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orbital Fat Prolapse

Keywords

orbital Computed Tomography, baggy eyelids, orbital fat prolapse, UltheraTM, high intensity focused ultrasound

Brief summary

Study title * Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid Study design * single arm and Investigator Initiative pilot study

Interventions

DEVICEUltheraTM 100 shots

UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe

Sponsors

Ulthera, Inc
CollaboratorINDUSTRY
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age \>20 years, Age \< 50 years * people who want to improve baggy eyelid * Information consent obtained

Exclusion criteria

* previous lower eyelid surgical history * scar on lower eyelid after trauma * bleeding tendency * aesthetic addiction, drug abuse, alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
The distance from the inferior orbital rim to the skinChange from Screening in distance at 12weeks after Ulthera treatmentDifference between the distance ( from the inferior orbital rim to the skin) measured by orbital CT at Screening and 12weeks after UltheraTM treatment

Secondary

MeasureTime frameDescription
The distance from the most protrusive baggy eyelid to the orbital septumChange from Screening in distance at 12weeks after UltheraTM treatmentThe distance(mm),from the most protrusive baggy eyelid to the orbital septum will be measured by a plastic surgeon with orbital CT films. Each participant will do Orbital CT scan 2 times, at screening and 12weeks after treatment
Subject Satisfaction for baggy lower eyelidChange from Screening in satisfaction at 4 weeks and 12weeks5-point scale for Subject Satisfaction in baggy lower eyelid. The subject satisfaction is calculated as a score between 0 and 4( 0= very poor, 4= very good).
Improvement of baggy lower eyelidChange from Screening in baggy lower eyelid at 12weeks after UltheraTM treatmentImprovement of baggy lower eyelid will be assessed by Two plastic surgeons. Both assessors will evaluate Improvement of baggy lower eyelid including skin laxity and orbital fat prolapse using 5-point scale. 0= no involvement 1. mild 2. moderate 3. marked 4. severe

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026